HanAll Biopharma Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
17,989
13,810
48,264
54,943
95,597
89,356
Total Accounts Receivable
23,493
29,096
23,597
22,921
19,117
18,076
Inventories
18,103
19,025
19,919
17,626
16,452
15,520
Other Current Assets
1,729
1,369
989
947
7,206
5,458
Total Current Assets
61,314
63,300
92,769
96,436
138,372
128,409
Net Property, Plant & Equipment
12,204
11,859
12,179
13,779
13,378
13,769
Total Investments and Advances
805
1,303
2,479
1,782
1,761
6,141
Intangible Assets
20,873
9,009
9,699
11,654
10,161
5,525
Other Assets
1,181
58
-
1,079
988
5,227
Total Assets
97,852
87,171
117,126
124,731
168,696
162,304
ST Debt & Current Portion LT Debt
17,280
17,194
-
-
-
Accounts Payable
3,206
6,405
4,816
6,518
5,153
Income Tax Payable
-
-
-
-
902
Other Current Liabilities
12,459
9,593
9,266
7,876
46,733
Total Current Liabilities
32,946
33,192
14,082
14,394
52,788
Long-Term Debt
-
3,000
-
-
-
Provision for Risks & Charges
2,364
2,599
5,112
3,422
3,373
Deferred Taxes
1,474
1,641
-
-
4,036
Other Liabilities
2,916
2,571
2,715
2,558
1,337
Total Liabilities
38,225
41,362
21,909
20,373
57,498
Common Equity (Total)
59,626
45,809
95,216
104,357
111,198
Total Shareholders' Equity
59,626
45,809
95,216
104,357
111,198
Total Equity
59,626
45,809
95,216
104,357
111,198
Liabilities & Shareholders' Equity
97,852
87,171
117,126
124,731
168,696
About HanAll Biopharma Co.
View Profile
